DK169732B1 - E. coli ATCC 39170 indeholdende plasmidet pCR2001, plasmidet pCR2001 og fremgangsmåde til fremstilling af kalve-prorennin uden de første 5 aminosyrer - Google Patents

E. coli ATCC 39170 indeholdende plasmidet pCR2001, plasmidet pCR2001 og fremgangsmåde til fremstilling af kalve-prorennin uden de første 5 aminosyrer Download PDF

Info

Publication number: DK169732B1
Authority: DK; Denmark
Prior art keywords: prorennin; coli; plasmid; cdna; pcr2001
Prior art date: 1981-08-24

Application number

DK377182A

Other languages

Danish (da)

English (en)

Other versions

DK377182A (da

Inventor

Teruhiko Beppu

Takeshi Uozumi

Katsuhiko Nishimori

Original Assignee

Teruhiko Beppu

Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)

1981-08-24

Filing date

1982-08-23

Publication date

1995-01-30

1982-08-23 Application filed by Teruhiko Beppu filed Critical Teruhiko Beppu

1983-02-25 Publication of DK377182A publication Critical patent/DK377182A/da

1995-01-30 Application granted granted Critical

1995-01-30 Publication of DK169732B1 publication Critical patent/DK169732B1/da

Links

239000013612 plasmid Substances 0.000 title claims abstract description 51
241000588724 Escherichia coli Species 0.000 title claims abstract description 24
244000309466 calf Species 0.000 title claims abstract description 19
150000001413 amino acids Chemical class 0.000 title claims description 4
108010064037 prorennin Proteins 0.000 title abstract description 81
238000004519 manufacturing process Methods 0.000 title abstract description 5
238000000034 method Methods 0.000 claims abstract description 26
244000005700 microbiome Species 0.000 claims abstract description 12
235000015097 nutrients Nutrition 0.000 claims abstract description 3
230000008569 process Effects 0.000 claims description 5
239000002299 complementary DNA Substances 0.000 abstract description 58
108090000746 Chymosin Proteins 0.000 abstract description 9
238000009396 hybridization Methods 0.000 abstract description 8
238000013519 translation Methods 0.000 abstract description 8
230000009466 transformation Effects 0.000 abstract description 5
238000000338 in vitro Methods 0.000 abstract description 4
102000004190 Enzymes Human genes 0.000 abstract description 3
108090000790 Enzymes Proteins 0.000 abstract description 3
230000001112 coagulating effect Effects 0.000 abstract description 3
239000008267 milk Substances 0.000 abstract description 3
210000004080 milk Anatomy 0.000 abstract description 3
235000013336 milk Nutrition 0.000 abstract description 3
108010062466 Enzyme Precursors Proteins 0.000 abstract description 2
102000010911 Enzyme Precursors Human genes 0.000 abstract description 2
210000003165 abomasum Anatomy 0.000 abstract description 2
239000002243 precursor Substances 0.000 abstract description 2
241000894006 Bacteria Species 0.000 abstract 1
108091026890 Coding region Proteins 0.000 abstract 1
238000005215 recombination Methods 0.000 abstract 1
230000006798 recombination Effects 0.000 abstract 1
108020004414 DNA Proteins 0.000 description 43
108020004999 messenger RNA Proteins 0.000 description 30
239000012634 fragment Substances 0.000 description 21
239000002585 base Substances 0.000 description 16
FAPWRFPIFSIZLT-UHFFFAOYSA-M Sodium chloride Chemical compound [Na+].[Cl-] FAPWRFPIFSIZLT-UHFFFAOYSA-M 0.000 description 14
229920001519 homopolymer Polymers 0.000 description 13
LFQSCWFLJHTTHZ-UHFFFAOYSA-N Ethanol Chemical compound CCO LFQSCWFLJHTTHZ-UHFFFAOYSA-N 0.000 description 10
239000000243 solution Substances 0.000 description 10
230000014616 translation Effects 0.000 description 10
102100031780 Endonuclease Human genes 0.000 description 8
ZHNUHDYFZUAESO-UHFFFAOYSA-N Formamide Chemical compound NC=O ZHNUHDYFZUAESO-UHFFFAOYSA-N 0.000 description 8
108090000623 proteins and genes Proteins 0.000 description 8
108091032973 (ribonucleotides)n+m Proteins 0.000 description 7
108010008286 DNA nucleotidylexotransferase Proteins 0.000 description 7
102100033215 DNA nucleotidylexotransferase Human genes 0.000 description 7
229960000723 ampicillin Drugs 0.000 description 7
AVKUERGKIZMTKX-NJBDSQKTSA-N ampicillin Chemical compound C1([C@@H](N)C(=O)N[C@H]2[C@H]3SC([C@@H](N3C2=O)C(O)=O)(C)C)=CC=CC=C1 AVKUERGKIZMTKX-NJBDSQKTSA-N 0.000 description 7
230000000295 complement effect Effects 0.000 description 7
239000011780 sodium chloride Substances 0.000 description 7
QKNYBSVHEMOAJP-UHFFFAOYSA-N 2-amino-2-(hydroxymethyl)propane-1,3-diol;hydron;chloride Chemical compound Cl.OCC(N)(CO)CO QKNYBSVHEMOAJP-UHFFFAOYSA-N 0.000 description 6
239000002244 precipitate Substances 0.000 description 6
102000053602 DNA Human genes 0.000 description 5
KCXVZYZYPLLWCC-UHFFFAOYSA-N EDTA Chemical compound OC(=O)CN(CC(O)=O)CCN(CC(O)=O)CC(O)=O KCXVZYZYPLLWCC-UHFFFAOYSA-N 0.000 description 5
108010092799 RNA-directed DNA polymerase Proteins 0.000 description 5
108020004682 Single-Stranded DNA Proteins 0.000 description 5
239000004098 Tetracycline Substances 0.000 description 5
239000007853 buffer solution Substances 0.000 description 5
229960002180 tetracycline Drugs 0.000 description 5
229930101283 tetracycline Natural products 0.000 description 5
235000019364 tetracycline Nutrition 0.000 description 5
150000003522 tetracyclines Chemical class 0.000 description 5
239000001226 triphosphate Substances 0.000 description 5
235000011178 triphosphate Nutrition 0.000 description 5
HEDRZPFGACZZDS-UHFFFAOYSA-N Chloroform Chemical compound ClC(Cl)Cl HEDRZPFGACZZDS-UHFFFAOYSA-N 0.000 description 4
102000004594 DNA Polymerase I Human genes 0.000 description 4
108010017826 DNA Polymerase I Proteins 0.000 description 4
ISWSIDIOOBJBQZ-UHFFFAOYSA-N Phenol Chemical compound OC1=CC=CC=C1 ISWSIDIOOBJBQZ-UHFFFAOYSA-N 0.000 description 4
229920002684 Sepharose Polymers 0.000 description 4
KWGKDLIKAYFUFQ-UHFFFAOYSA-M lithium chloride Chemical compound [Li+].[Cl-] KWGKDLIKAYFUFQ-UHFFFAOYSA-M 0.000 description 4
239000002609 medium Substances 0.000 description 4
239000000203 mixture Substances 0.000 description 4
210000004877 mucosa Anatomy 0.000 description 4
239000000047 product Substances 0.000 description 4
210000002784 stomach Anatomy 0.000 description 4
125000002264 triphosphate group Chemical class [H]OP(=O)(O[H])OP(=O)(O[H])OP(=O)(O[H])O* 0.000 description 4
PCDQPRRSZKQHHS-XVFCMESISA-N CTP Chemical compound O=C1N=C(N)C=CN1[C@H]1[C@H](O)[C@H](O)[C@@H](COP(O)(=O)OP(O)(=O)OP(O)(O)=O)O1 PCDQPRRSZKQHHS-XVFCMESISA-N 0.000 description 3
102000012410 DNA Ligases Human genes 0.000 description 3
108010061982 DNA Ligases Proteins 0.000 description 3
108010054576 Deoxyribonuclease EcoRI Proteins 0.000 description 3
108010042407 Endonucleases Proteins 0.000 description 3
101710163270 Nuclease Proteins 0.000 description 3
HEMHJVSKTPXQMS-UHFFFAOYSA-M Sodium hydroxide Chemical compound [OH-].[Na+] HEMHJVSKTPXQMS-UHFFFAOYSA-M 0.000 description 3
229930006000 Sucrose Natural products 0.000 description 3
CZMRCDWAGMRECN-UGDNZRGBSA-N Sucrose Chemical compound O[C@H]1[C@H](O)[C@@H](CO)O[C@@]1(CO)O[C@@H]1[C@H](O)[C@@H](O)[C@H](O)[C@@H](CO)O1 CZMRCDWAGMRECN-UGDNZRGBSA-N 0.000 description 3
125000003275 alpha amino acid group Chemical group 0.000 description 3
210000004027 cell Anatomy 0.000 description 3
238000006243 chemical reaction Methods 0.000 description 3
238000010367 cloning Methods 0.000 description 3
HAAZLUGHYHWQIW-KVQBGUIXSA-N dGTP Chemical compound C1=NC=2C(=O)NC(N)=NC=2N1[C@H]1C[C@H](O)[C@@H](COP(O)(=O)OP(O)(=O)OP(O)(O)=O)O1 HAAZLUGHYHWQIW-KVQBGUIXSA-N 0.000 description 3
238000005516 engineering process Methods 0.000 description 3
239000000284 extract Substances 0.000 description 3
238000000855 fermentation Methods 0.000 description 3
230000004151 fermentation Effects 0.000 description 3
238000002360 preparation method Methods 0.000 description 3
238000001243 protein synthesis Methods 0.000 description 3
239000011541 reaction mixture Substances 0.000 description 3
239000000523 sample Substances 0.000 description 3
239000000126 substance Substances 0.000 description 3
239000005720 sucrose Substances 0.000 description 3
CSCPPACGZOOCGX-UHFFFAOYSA-N Acetone Chemical compound CC(C)=O CSCPPACGZOOCGX-UHFFFAOYSA-N 0.000 description 2
241000644323 Escherichia coli C Species 0.000 description 2
GUBGYTABKSRVRQ-QKKXKWKRSA-N Lactose Natural products OC[C@H]1O[C@@H](O[C@H]2[C@H](O)[C@@H](O)C(O)O[C@@H]2CO)[C@H](O)[C@@H](O)[C@H]1O GUBGYTABKSRVRQ-QKKXKWKRSA-N 0.000 description 2
108091005804 Peptidases Proteins 0.000 description 2
239000004365 Protease Substances 0.000 description 2
108020004511 Recombinant DNA Proteins 0.000 description 2
102100037486 Reverse transcriptase/ribonuclease H Human genes 0.000 description 2
230000002378 acidificating effect Effects 0.000 description 2
239000003463 adsorbent Substances 0.000 description 2
125000000539 amino acid group Chemical group 0.000 description 2
239000008346 aqueous phase Substances 0.000 description 2
239000007864 aqueous solution Substances 0.000 description 2
239000000440 bentonite Substances 0.000 description 2
229910000278 bentonite Inorganic materials 0.000 description 2
SVPXDRXYRYOSEX-UHFFFAOYSA-N bentoquatam Chemical compound O.O=[Si]=O.O=[Al]O[Al]=O SVPXDRXYRYOSEX-UHFFFAOYSA-N 0.000 description 2
230000015572 biosynthetic process Effects 0.000 description 2
159000000007 calcium salts Chemical class 0.000 description 2
238000005119 centrifugation Methods 0.000 description 2
125000004122 cyclic group Chemical group 0.000 description 2
230000000694 effects Effects 0.000 description 2
238000010828 elution Methods 0.000 description 2
238000000605 extraction Methods 0.000 description 2
238000005194 fractionation Methods 0.000 description 2
239000004615 ingredient Substances 0.000 description 2
150000002500 ions Chemical class 0.000 description 2
PHTQWCKDNZKARW-UHFFFAOYSA-N isoamylol Chemical compound CC(C)CCO PHTQWCKDNZKARW-UHFFFAOYSA-N 0.000 description 2
239000008101 lactose Substances 0.000 description 2
239000006166 lysate Substances 0.000 description 2
239000006916 nutrient agar Substances 0.000 description 2
229920000642 polymer Polymers 0.000 description 2
108091008146 restriction endonucleases Proteins 0.000 description 2
210000001995 reticulocyte Anatomy 0.000 description 2
LWIHDJKSTIGBAC-UHFFFAOYSA-K tripotassium phosphate Chemical compound [K+].[K+].[K+].[O-]P([O-])([O-])=O LWIHDJKSTIGBAC-UHFFFAOYSA-K 0.000 description 2
XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 description 2
PGSPUKDWUHBDKJ-UHFFFAOYSA-N 6,7-dihydro-3h-purin-2-amine Chemical compound C1NC(N)=NC2=C1NC=N2 PGSPUKDWUHBDKJ-UHFFFAOYSA-N 0.000 description 1
GGNHBHYDMUDXQB-KBIXCLLPSA-N Ala-Glu-Ile Chemical compound CC[C@H](C)[C@@H](C(O)=O)NC(=O)[C@H](CCC(O)=O)NC(=O)[C@H](C)N GGNHBHYDMUDXQB-KBIXCLLPSA-N 0.000 description 1
108010039224 Amidophosphoribosyltransferase Proteins 0.000 description 1
101100291031 Caenorhabditis elegans gly-13 gene Proteins 0.000 description 1
OYPRJOBELJOOCE-UHFFFAOYSA-N Calcium Chemical compound [Ca] OYPRJOBELJOOCE-UHFFFAOYSA-N 0.000 description 1
241000283707 Capra Species 0.000 description 1
CURLTUGMZLYLDI-UHFFFAOYSA-N Carbon dioxide Chemical compound O=C=O CURLTUGMZLYLDI-UHFFFAOYSA-N 0.000 description 1
229910021581 Cobalt(III) chloride Inorganic materials 0.000 description 1
108020004705 Codon Proteins 0.000 description 1
108010014303 DNA-directed DNA polymerase Proteins 0.000 description 1
102000016928 DNA-directed DNA polymerase Human genes 0.000 description 1
206010059866 Drug resistance Diseases 0.000 description 1
108060002716 Exonuclease Proteins 0.000 description 1
108700039691 Genetic Promoter Regions Proteins 0.000 description 1
108010051696 Growth Hormone Proteins 0.000 description 1
102100027368 Histone H1.3 Human genes 0.000 description 1
101001009450 Homo sapiens Histone H1.3 Proteins 0.000 description 1
102000014150 Interferons Human genes 0.000 description 1
108010050904 Interferons Proteins 0.000 description 1
102000003960 Ligases Human genes 0.000 description 1
108090000364 Ligases Proteins 0.000 description 1
108091036407 Polyadenylation Proteins 0.000 description 1
108091034057 RNA (poly(A)) Proteins 0.000 description 1
VMHLLURERBWHNL-UHFFFAOYSA-M Sodium acetate Chemical compound [Na+].CC([O-])=O VMHLLURERBWHNL-UHFFFAOYSA-M 0.000 description 1
102100038803 Somatotropin Human genes 0.000 description 1
MQBTXMPQNCGSSZ-OSUNSFLBSA-N Thr-Arg-Ile Chemical compound CC[C@H](C)[C@@H](C(O)=O)NC(=O)[C@@H](NC(=O)[C@@H](N)[C@@H](C)O)CCCN=C(N)N MQBTXMPQNCGSSZ-OSUNSFLBSA-N 0.000 description 1
ATJFFYVFTNAWJD-UHFFFAOYSA-N Tin Chemical compound [Sn] ATJFFYVFTNAWJD-UHFFFAOYSA-N 0.000 description 1
210000001015 abdomen Anatomy 0.000 description 1
230000009471 action Effects 0.000 description 1
238000001042 affinity chromatography Methods 0.000 description 1
238000000246 agarose gel electrophoresis Methods 0.000 description 1
239000003513 alkali Substances 0.000 description 1
239000006286 aqueous extract Substances 0.000 description 1
239000012736 aqueous medium Substances 0.000 description 1
239000011575 calcium Substances 0.000 description 1
229910052791 calcium Inorganic materials 0.000 description 1
229940041514 candida albicans extract Drugs 0.000 description 1
235000011089 carbon dioxide Nutrition 0.000 description 1
230000015556 catabolic process Effects 0.000 description 1
235000013351 cheese Nutrition 0.000 description 1
229940080701 chymosin Drugs 0.000 description 1
238000010276 construction Methods 0.000 description 1
238000007796 conventional method Methods 0.000 description 1
238000001816 cooling Methods 0.000 description 1
230000008878 coupling Effects 0.000 description 1
238000010168 coupling process Methods 0.000 description 1
238000005859 coupling reaction Methods 0.000 description 1
238000005520 cutting process Methods 0.000 description 1
230000006378 damage Effects 0.000 description 1
238000000354 decomposition reaction Methods 0.000 description 1
238000006731 degradation reaction Methods 0.000 description 1
238000000432 density-gradient centrifugation Methods 0.000 description 1
238000001514 detection method Methods 0.000 description 1
238000011161 development Methods 0.000 description 1
239000012153 distilled water Substances 0.000 description 1
229940088598 enzyme Drugs 0.000 description 1
230000001747 exhibiting effect Effects 0.000 description 1
102000013165 exonuclease Human genes 0.000 description 1
238000002474 experimental method Methods 0.000 description 1
239000000499 gel Substances 0.000 description 1
238000002523 gelfiltration Methods 0.000 description 1
230000002068 genetic effect Effects 0.000 description 1
239000000122 growth hormone Substances 0.000 description 1
239000012535 impurity Substances 0.000 description 1
238000011534 incubation Methods 0.000 description 1
229940079322 interferon Drugs 0.000 description 1
238000002955 isolation Methods 0.000 description 1
BPHPUYQFMNQIOC-NXRLNHOXSA-N isopropyl beta-D-thiogalactopyranoside Chemical compound CC(C)S[C@@H]1O[C@H](CO)[C@H](O)[C@H](O)[C@H]1O BPHPUYQFMNQIOC-NXRLNHOXSA-N 0.000 description 1
238000001738 isopycnic centrifugation Methods 0.000 description 1
239000000463 material Substances 0.000 description 1
238000005259 measurement Methods 0.000 description 1
230000000813 microbial effect Effects 0.000 description 1
239000012046 mixed solvent Substances 0.000 description 1
238000012986 modification Methods 0.000 description 1
230000004048 modification Effects 0.000 description 1
GNOLWGAJQVLBSM-UHFFFAOYSA-N n,n,5,7-tetramethyl-1,2,3,4-tetrahydronaphthalen-1-amine Chemical compound C1=C(C)C=C2C(N(C)C)CCCC2=C1C GNOLWGAJQVLBSM-UHFFFAOYSA-N 0.000 description 1
239000002773 nucleotide Substances 0.000 description 1
-1 nucleotide triphosphates Chemical class 0.000 description 1
229920002401 polyacrylamide Polymers 0.000 description 1
239000011148 porous material Substances 0.000 description 1
229910000160 potassium phosphate Inorganic materials 0.000 description 1
235000011009 potassium phosphates Nutrition 0.000 description 1
HJRIWDYVYNNCFY-UHFFFAOYSA-M potassium;dimethylarsinate Chemical compound [K+].C[As](C)([O-])=O HJRIWDYVYNNCFY-UHFFFAOYSA-M 0.000 description 1
239000000843 powder Substances 0.000 description 1
108010090894 prolylleucine Proteins 0.000 description 1
102000004169 proteins and genes Human genes 0.000 description 1
238000000746 purification Methods 0.000 description 1
238000010791 quenching Methods 0.000 description 1
230000000171 quenching effect Effects 0.000 description 1
230000002285 radioactive effect Effects 0.000 description 1
238000003127 radioimmunoassay Methods 0.000 description 1
230000008439 repair process Effects 0.000 description 1
238000011160 research Methods 0.000 description 1
108020004418 ribosomal RNA Proteins 0.000 description 1
210000003705 ribosome Anatomy 0.000 description 1
238000004062 sedimentation Methods 0.000 description 1
239000001632 sodium acetate Substances 0.000 description 1
235000017281 sodium acetate Nutrition 0.000 description 1
239000001509 sodium citrate Substances 0.000 description 1
NLJMYIDDQXHKNR-UHFFFAOYSA-K sodium citrate Chemical compound O.O.[Na+].[Na+].[Na+].[O-]C(=O)CC(O)(CC([O-])=O)C([O-])=O NLJMYIDDQXHKNR-UHFFFAOYSA-K 0.000 description 1
ZNJHFNUEQDVFCJ-UHFFFAOYSA-M sodium;2-[4-(2-hydroxyethyl)piperazin-1-yl]ethanesulfonic acid;hydroxide Chemical compound [OH-].[Na+].OCCN1CCN(CCS(O)(=O)=O)CC1 ZNJHFNUEQDVFCJ-UHFFFAOYSA-M 0.000 description 1
239000007790 solid phase Substances 0.000 description 1
238000000527 sonication Methods 0.000 description 1
238000001179 sorption measurement Methods 0.000 description 1
241000894007 species Species 0.000 description 1
238000003756 stirring Methods 0.000 description 1
238000003786 synthesis reaction Methods 0.000 description 1
239000012137 tryptone Substances 0.000 description 1
238000005406 washing Methods 0.000 description 1
239000012138 yeast extract Substances 0.000 description 1
DGVVWUTYPXICAM-UHFFFAOYSA-N β‐Mercaptoethanol Chemical compound OCCS DGVVWUTYPXICAM-UHFFFAOYSA-N 0.000 description 1

Classifications

- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N9/00—Enzymes; Proenzymes; Compositions thereof; Processes for preparing, activating, inhibiting, separating or purifying enzymes
- C12N9/14—Hydrolases (3)
- C12N9/48—Hydrolases (3) acting on peptide bonds (3.4)
- C12N9/50—Proteinases, e.g. Endopeptidases (3.4.21-3.4.25)
- C12N9/64—Proteinases, e.g. Endopeptidases (3.4.21-3.4.25) derived from animal tissue
- C12N9/6421—Proteinases, e.g. Endopeptidases (3.4.21-3.4.25) derived from animal tissue from mammals
- C12N9/6478—Aspartic endopeptidases (3.4.23)
- C12N9/6481—Pepsins (3.4.23.1; 3.4.23.2; 3.4.23.3)
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N9/00—Enzymes; Proenzymes; Compositions thereof; Processes for preparing, activating, inhibiting, separating or purifying enzymes
- C12N9/14—Hydrolases (3)
- C12N9/48—Hydrolases (3) acting on peptide bonds (3.4)
- C12N9/50—Proteinases, e.g. Endopeptidases (3.4.21-3.4.25)
- C12N9/52—Proteinases, e.g. Endopeptidases (3.4.21-3.4.25) derived from bacteria or Archaea

Landscapes

Health & Medical Sciences (AREA)
Life Sciences & Earth Sciences (AREA)
Chemical & Material Sciences (AREA)
Engineering & Computer Science (AREA)
Wood Science & Technology (AREA)
Organic Chemistry (AREA)
Bioinformatics & Cheminformatics (AREA)
Zoology (AREA)
Genetics & Genomics (AREA)
Biomedical Technology (AREA)
Molecular Biology (AREA)
Microbiology (AREA)
Biotechnology (AREA)
Biochemistry (AREA)
General Engineering & Computer Science (AREA)
General Health & Medical Sciences (AREA)
Medicinal Chemistry (AREA)
Micro-Organisms Or Cultivation Processes Thereof (AREA)
Preparation Of Compounds By Using Micro-Organisms (AREA)
Medicines Containing Plant Substances (AREA)
Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Steroid Compounds (AREA)
Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
Saccharide Compounds (AREA)

DK377182A 1981-08-24 1982-08-23 E. coli ATCC 39170 indeholdende plasmidet pCR2001, plasmidet pCR2001 og fremgangsmåde til fremstilling af kalve-prorennin uden de første 5 aminosyrer DK169732B1 (da)

Applications Claiming Priority (2)

Application Number	Priority Date	Filing Date	Title
JP13163181		1981-08-24
JP56131631A JPS5832896A (ja)	1981-08-24	1981-08-24	複合プラスミド及びそれを含有する微生物

Publications (2)

Publication Number	Publication Date
DK377182A DK377182A (da)	1983-02-25
DK169732B1 true DK169732B1 (da)	1995-01-30

Family

ID=15062560

Family Applications (1)

Application Number	Title	Priority Date	Filing Date
DK377182A DK169732B1 (da)	1981-08-24	1982-08-23	E. coli ATCC 39170 indeholdende plasmidet pCR2001, plasmidet pCR2001 og fremgangsmåde til fremstilling af kalve-prorennin uden de første 5 aminosyrer

Country Status (8)

Country	Link
EP (1)	EP0073029B1 (fr)
JP (1)	JPS5832896A (fr)
AT (1)	ATE30741T1 (fr)
BR (1)	BR8204898A (fr)
CA (1)	CA1340214C (fr)
DE (1)	DE3277631D1 (fr)
DK (1)	DK169732B1 (fr)
IE (1)	IE53555B1 (fr)

Families Citing this family (12)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
US5525484A (en) *	1981-01-16	1996-06-11	Genome Therapeutics Corp.	Recombinant DNA means and method for producing rennin, prorenin and pre-prorennin
IL68797A0 (en) *	1982-07-01	1983-09-30	Genex Corp	Cloned bovine calf chymosin and calf prochymosin genes,their preparation,plasmids containing them and microorganisms transformed by those plasmids
IE56372B1 (en) *	1982-12-22	1991-07-03	Genentech Inc	Microbially produced rennet methods for its production and plasmids used for its production
JPS59166086A (ja) *	1983-03-09	1984-09-19	Teruhiko Beppu	新規な発現型プラスミドとそれらを用いて仔牛プロキモシン遺伝子を大腸菌内で発現させる方法
EP0123928A3 (fr) *	1983-03-31	1986-02-05	Codon Genetic Engineering Laboratories	ADN recombinant codant pour un polypeptide présentant une activité de coagulation du lait
US4721673A (en) *	1983-09-01	1988-01-26	Genex Corporation	Recovery and activation process for microbially produced calf prochymosin
US4935370A (en) *	1983-12-23	1990-06-19	Pfizer Inc.	Expression plasmids for improved production of heterologous protein in bacteria
JPS60188093A (ja) *	1984-03-09	1985-09-25	Teruhiko Beppu	枯草菌に於ける形質発現プラスミド
JPS60207583A (ja) *	1984-03-29	1985-10-19	Sankyo Co Ltd	ブタ・膵臓エラスタ−ゼ
US5082775A (en) *	1984-05-11	1992-01-21	Berlex Laboratories, Inc.	Efficient process for isolating insoluble heterologous protein using non-ionic detergents
US4801537A (en) *	1984-06-08	1989-01-31	Genex Corporation	Vector for expression of polypeptides in bacilli
EP1745068A4 (fr) *	2004-03-30	2009-11-04	Sudershan Biotech Ltd	Chymosine de veau de recombinaison et procede de fabrication

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
US4666847A (en) *	1981-01-16	1987-05-19	Collaborative Research, Inc.	Recombinant DNA means and method

1981
- 1981-08-24 JP JP56131631A patent/JPS5832896A/ja active Pending
1982
- 1982-08-19 DE DE8282107601T patent/DE3277631D1/de not_active Expired
- 1982-08-19 AT AT82107601T patent/ATE30741T1/de not_active IP Right Cessation
- 1982-08-19 EP EP82107601A patent/EP0073029B1/fr not_active Expired
- 1982-08-20 BR BR8204898A patent/BR8204898A/pt unknown
- 1982-08-23 CA CA000409941A patent/CA1340214C/fr not_active Expired - Lifetime
- 1982-08-23 IE IE2018/82A patent/IE53555B1/en not_active IP Right Cessation
- 1982-08-23 DK DK377182A patent/DK169732B1/da not_active IP Right Cessation

Also Published As

Publication number	Publication date
IE822018L (en)	1983-02-24
IE53555B1 (en)	1988-12-07
DE3277631D1 (en)	1987-12-17
JPS5832896A (ja)	1983-02-25
EP0073029A3 (en)	1983-06-29
BR8204898A (pt)	1983-08-02
DK377182A (da)	1983-02-25
ATE30741T1 (de)	1987-11-15
EP0073029A2 (fr)	1983-03-02
CA1340214C (fr)	1998-12-15
EP0073029B1 (fr)	1987-11-11

Legal Events

Date	Code	Title	Description
1995-01-30	B1	Patent granted (law 1993)
1999-05-10	PBP	Patent lapsed

Publication	Publication Date	Title
DK169732B1 (da)	1995-01-30	E. coli ATCC 39170 indeholdende plasmidet pCR2001, plasmidet pCR2001 og fremgangsmåde til fremstilling af kalve-prorennin uden de første 5 aminosyrer
JP2968052B2 (ja)	1999-10-25	微生物によるヒト血清アルブミンの製造方法
Dickinson et al.	1994	Crystals of the cell-binding module of fibronectin obtained from a series of recombinant fragments differing in length
KR100316347B1 (ko)	2002-08-27	대장균엔테로톡신ⅱ신호펩티드의변형체와인체성장호르몬의융합단백질을발현하는재조합미생물및그를이용한인체성장호르몬의제조방법
RU2354703C2 (ru)	2009-05-10	Продуцирование il-21 в прокариотических клетках-хозяевах
EP0104920B1 (fr)	1992-06-10	Séquences d'ADN, molécules d'ADN recombinantes et procédés pour la production des polypeptides semblables à l'hormone de la croissance du porc
CN1162542C (zh)	2004-08-18	一种植物外源凝集素基因
NO159392B (no)	1988-09-12	Fremgangsmaate for fremstilling av modent ikke-glykosylertinterferon.
SE455794B (sv)	1988-08-08	Plasmid med nukleotidsekvens som kodar for aminosyrasekvensen i humant tillvexthormon och forfarande for framstellning derav
WO2007107882A2 (fr)	2007-09-27	Procede de purification du facteur stimulant la formation de colonies de granulocytes
CN105296454A (zh)	2016-02-03	一种褐藻胶裂解酶基因algp及其制备方法与表达
CN112646767B (zh)	2022-08-09	具有增强的l-谷氨酸生产力的菌株及其构建方法与应用
CN113943737A (zh)	2022-01-18	一种鸡ctgf基因在抑制鸡前脂肪细胞分化的应用
CN114181321B (zh)	2023-04-11	花鲈fgf6a、fgf6b以及fgf18重组蛋白及其制备方法和应用
EP1185675B1 (fr)	2005-11-30	Souche d'escherichia coli secretant le facteur stimulant les colonies de granulocytes humains (g-csf)
EP1656455B1 (fr)	2012-09-19	Procédé de purification des polypeptides recombinants
AU643194B2 (en)	1993-11-11	Recombinant fish hormone proteins
Daimon et al.	1997	Identification of a Human cDNA Homologue to theDrosophilaTranslocation Protein 1 (Dtrp1)
Granados-Baeza et al.	2007	Novel reiterated Fnr-type proteins control the production of the symbiotic terminal oxidase cbb 3 in Rhizobium etli CFN42
CN101619101B (zh)	2011-09-28	马铁菊头蝠瘦素蛋白及其cDNA序列
IE851225L (en)	1985-11-17	Peptides
NO834392L (no)	1983-11-29	Fremstilling av dna-sekvenser som koder for modifiserte proinsulinforloepere
CN114262368A (zh)	2022-04-01	一种重组Scl2类胶原蛋白及其可变速水凝胶的制备方法
Roytrakul et al.	2001	A Rapid and Simple Method for Construction and Expression of a Synthetic
RU2018145694A (ru)	2020-06-25	Генотерапевтический ДНК-вектор на основе генотерапевтического ДНК-вектора VTvaf17, несущий целевой ген, выбранный из группы генов NOS2, NOS3, VIP, KCNMA1, CGRP, для повышения уровня экспрессии этих целевых генов, способ его получения и применения, штамм Escherichia coli SCS110-AF/VTvaf17-NOS2, или Escherichia coli SCS110-AF/VTvaf17-NOS3, или Escherichia coli SCS110-AF/VTvaf17-VIP, или Escherichia coli SCS110-AF/VTvaf17-KCNMA1, или Escherichia coli SCS110-AF/VTvaf17-CGRP, несущий генотерапевтический ДНК-вектор, способ его получения, способ производства в промышленных масштабах генотерапевтического ДНК-вектора